sub:provenance {
beldoc: dce:description "Approximately 61,000 statements." ;
dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
dce:title "BEL Framework Large Corpus Document" ;
pav:authoredBy sub:_5 ;
pav:version "20131211" .
sub:_4 prov:value "Pretreatment of THP-1 cells with pharmacological inhibitors of PI3K (LY294002), MAPK (PD98059), p38 MAPK (SB203580), and JNK (SP600125) inhibited ET-1-mediated MIP-1b mRNA expression by 89 6 5%, 104 6 7%, 102 6 8%, and 118 6 1%, respectively, when compared with that of untreated cells (Fig.1B)." ;
prov:wasQuotedFrom pubmed:20952681 .
sub:_5 rdfs:label "Selventa" .
sub:assertion prov:hadPrimarySource pubmed:20952681 ;
prov:wasDerivedFrom beldoc: ,
sub:_4 .
}